Application Deadline: May 1st, 2019
Life Science Nation invites the top-tier early-stage companies in therapeutics, medical devices, diagnostics, and digital health from around the globe to apply for the RESI Innovation and Pitch Challenge.
There is no fee to apply. Please send additional materials such as your pitch deck and executive summary to RESI@lifesciencenation.com for us to review along with your application to the RESI Innovation and Pitch Challenges.
The RESI Innovation Challenge finalists will present a poster on the day of the conference in the Exhibition Hall. Every attendee receives ‘RESI cash’ to ‘invest’ in their favorite companies, and the top three companies will receive prizes at the end of the day. All participating finalists are required to bring a poster board to present their technologies. The poster board deadline with our preferred printer in Philadelphia is Friday, May 24th.
If your company won (1st - 3rd place) an Innovation Challenge since RESI Boston in June 2018, or were a finalist at RESI Europe in March 2019, you do not qualify to participate in the Innovation Challenge at RESI Philadelphia 2019. The RESI Innovation Challenge is dedicated to showcasing early stage technologies. A commercial stage company (except digital health) would not be a fit for this Challenge. Please fill out this form as completely as possible.
The RESI Pitch Challenge is for the earliest stage companies associated with tech hubs*. The companies selected will have the opportunity to pitch to a panel of investors at RESI. *Tech hubs are defined as incubators, accelerators, tech transfer offices, universities, hospitals and research labs.
Please note: If you are selected as a finalist, and you have not yet registered for the conference, you MUST register to claim your spot in the RESI Innovation or Pitch Challenges.
Having trouble applying for Innovation Challenge?
Click here to download the PDF version of the application, then fill out the form and send it to RESI@lifesciencenation.com along with any required additional materials such as your pitch deck and executive summary. We apologize for any inconvenience.